Maven Securities LTD Purchases New Shares in Medline $MDLN

Maven Securities LTD purchased a new stake in Medline (NASDAQ:MDLN) in the 4th quarter, Holdings Channel.com reports. The institutional investor purchased 100,000 shares of the company’s stock, valued at approximately $4,200,000.

Other institutional investors have also added to or reduced their stakes in the company. Sound Income Strategies LLC bought a new stake in Medline in the 4th quarter valued at $25,000. Entrust Financial LLC bought a new stake in Medline in the 4th quarter valued at $26,000. NBC Securities Inc. bought a new stake in Medline in the 4th quarter valued at $28,000. Global Retirement Partners LLC bought a new stake in Medline in the 4th quarter valued at $31,000. Finally, North Star Investment Management Corp. bought a new stake in Medline in the 4th quarter valued at $36,000.

Medline Stock Performance

NASDAQ:MDLN opened at $36.61 on Monday. The firm’s fifty day moving average is $40.76. The company has a market cap of $48.09 billion and a P/E ratio of 114.41. The company has a current ratio of 4.41, a quick ratio of 2.51 and a debt-to-equity ratio of 0.65. Medline has a fifty-two week low of $32.81 and a fifty-two week high of $50.88.

Medline (NASDAQ:MDLN) last released its earnings results on Wednesday, May 6th. The company reported $0.33 earnings per share for the quarter, beating analysts’ consensus estimates of $0.29 by $0.04. The company had revenue of $7.35 billion for the quarter. The firm’s quarterly revenue was up 10.7% compared to the same quarter last year. Research analysts predict that Medline will post 1.51 EPS for the current fiscal year.

Insider Buying and Selling at Medline

In other Medline news, insider Jessi L. Corcoran acquired 5,000 shares of the company’s stock in a transaction that occurred on Friday, June 5th. The stock was acquired at an average cost of $34.15 per share, for a total transaction of $170,750.00. Following the transaction, the insider directly owned 5,000 shares in the company, valued at $170,750. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. 0.81% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several analysts recently issued reports on MDLN shares. Robert W. Baird reduced their price target on Medline from $57.00 to $45.00 and set an “outperform” rating for the company in a research note on Wednesday, June 3rd. Citigroup cut their target price on Medline from $60.00 to $55.00 and set a “buy” rating for the company in a research report on Thursday, May 7th. Morgan Stanley upped their target price on Medline from $48.00 to $52.00 and gave the company an “overweight” rating in a research report on Monday, March 2nd. BMO Capital Markets upped their target price on Medline from $45.00 to $54.00 and gave the company an “outperform” rating in a research report on Thursday, February 26th. Finally, Stifel Nicolaus set a $55.00 target price on Medline in a research report on Wednesday, February 25th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-two have given a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $50.54.

Medline Company Profile

Medline (NASDAQ: MDLN) is a healthcare products and services company that manufactures, sources and distributes a wide range of medical supplies and equipment for healthcare providers. Its product portfolio spans clinical consumables and personal protective equipment, surgical and procedural supplies, wound care and incontinence products, diagnostic and laboratory supplies, and select durable medical equipment. Medline supports care settings that include hospitals, health systems, long-term care facilities, ambulatory clinics and home health providers.

In addition to product manufacturing and distribution, Medline provides supply‑chain and logistics services designed to help healthcare customers manage inventory, reduce costs and streamline operations.